Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles

References

• de JongeJHoltropMWilschutJHuckriedeAReconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAsGene Ther200613540041116267567
   PubMed Web of Science ®Google Scholar
• de FougerollesAVornlocherHPMaraganoreJLiebermanJInterfering with disease: a progress report on siRNA-based therapeuticsNat Rev Drug Discov20076644345317541417
   PubMed Web of Science ®Google Scholar
• GaoJLiuWXiaYThe promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomesBiomaterials201132133459347021296406
   PubMed Web of Science ®Google Scholar
• FavaroEIndraccoloSGene therapy of cancer in the clinic: good news in sight from Asia?Curr Opin Mol Ther20079547748217932811
   PubMedGoogle Scholar
• PirolloKFRaitAZhouQMaterializing the potential of small interfering RNA via a tumor-targeting nanodelivery systemCancer Res20076772938294317409398
   PubMed Web of Science ®Google Scholar
• TsengYCMozumdarSHuangLLipid-based systemic delivery of siRNAAdv Drug Deliv Rev200961972173119328215
   PubMed Web of Science ®Google Scholar
• LiSHuangLNonviral gene therapy: promises and challengesGene Ther200071313410680013
   PubMed Web of Science ®Google Scholar
• LiSDChonoSHuangLEfficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticlesJ Control Release20081261778418083264
   PubMed Web of Science ®Google Scholar
• LiSDChenYCHackettMJHuangLTumor-targeted delivery of siRNA by self-assembled nanoparticlesMol Ther200816116316917923843
   PubMed Web of Science ®Google Scholar
• SandersonCMAvalosRKunduANayakDPInteraction of Sendai viral F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cellsVirology199520927017077778306
   PubMed Web of Science ®Google Scholar
• BakerMRNA interference: homing in on deliveryNature2010464729212251228
   Web of Science ®Google Scholar
• MorilleMPassiraniCVonarbourgAClavreulABenoitJPProgress in developing cationic vectors for non-viral systemic gene therapy against cancerBiomaterials20082924–253477349618499247
   PubMed Web of Science ®Google Scholar
• GaoJFengSSGuoYAntibody engineering promotes nanomedicine for cancer treatmentNanomedicine2010581141114521039191
   PubMed Web of Science ®Google Scholar
• NicholsonRIGeeJMHarperMEEGFR and cancer prognosisEur J Cancer2001374suppl 4915
   Google Scholar
• RansonMZD1839 (Iressa): for more than just non-small cell lung cancerOncologist20027suppl 4162412202784
   PubMedGoogle Scholar
• RaymondEFaivreSArmandJPEpidermal growth factor receptor tyrosine kinase as a target for anticancer therapyDrugs200060suppl 11523 discussion 41–1211129168
   PubMed Web of Science ®Google Scholar
• MishaniEHagoolyAStrategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancerJ Nucl Med20095081199120219617320
   PubMed Web of Science ®Google Scholar
• TolmachevVFriedmanMSandströmMAffibody molecules for epidermal growth factor receptor targeting in vivo: aspects of dimerization and labeling chemistryJ Nucl Med200950227428319164241
   PubMed Web of Science ®Google Scholar
• GelovaniJGMolecular imaging of epidermal growth factor receptor expression-activity at the kinase level in tumors with positron emission tomographyCancer Metastasis Rev200827464565318626573
   PubMed Web of Science ®Google Scholar
• MishaniEAbourbehGRozenYNovel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumorsNucl Med Biol200431446947615093817
   PubMed Web of Science ®Google Scholar
• LahatGZhuQSHuangKLVimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studiesPLoS One201054e1010520419128
   PubMed Web of Science ®Google Scholar
• EckesBColucci-GuyonESmolaHImpaired wound healing in embryonic and adult mice lacking vimentinJ Cell Sci2000113pt 132455246210852824
   PubMed Web of Science ®Google Scholar
• Bargagna-MohanPHamzaAKimYEThe tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinChem Biol200714662363417584610
   PubMedGoogle Scholar
• McinroyLMäättäADown-regulation of vimentin expression inhibits carcinoma cell migration and adhesionBiochem Biophys Res Commun2007360110911417585878
   PubMed Web of Science ®Google Scholar
• WuWSunXHJanus kinase 3: the controller and the controlledActa Biochim Biophys Sin201244318719622130498
   PubMedGoogle Scholar
• O’SheaJJGadinaMSchreiberRDCytokine signaling in 2002: new surprises in the Jak/Stat pathwayCell2002109supplS121S13111983158
   PubMed Web of Science ®Google Scholar
• KlinkMKielbikMNowakMBednarskaKSulowskaZJAK3, STAT3 and CD3-zeta signaling proteins status in regard to the lymphocytes function in patients with ovarian cancerImmunol Invest201241438239822221142
   PubMed Web of Science ®Google Scholar
• KimHSKimJSLeeYKKooKHParkYSAn efficient liposomal gene delivery vehicle using Sendai F/HN proteins and protamineCancer Gene Ther200815421422418259213
   PubMed Web of Science ®Google Scholar
• LaneEBHoganBLKurkinenMGarrelsJICo-expression of vimentin and cytokeratins in parietal endoderm cells of early mouse embryoNature198330359197017046190091
   PubMed Web of Science ®Google Scholar
• HendrixMJSeftorEAChuYWCoexpression of vimentin and keratins by human melanoma tumor cells: correlation with invasive and metastatic potentialJ Natl Cancer Inst19928431651741371813
   PubMedGoogle Scholar
• O’RourkeNADaileyMESmithSJMcconnellSKDiverse migratory pathways in the developing cerebral cortexScience199225850802993021411527
   PubMed Web of Science ®Google Scholar
• HendrixMJSeftorEAChuYWTrevorKTSeftorRERole of intermediate filaments in migration, invasion and metastasisCancer Metastasis Rev19961545075259034607
   PubMed Web of Science ®Google Scholar
• WangNStamenovicDMechanics of vimentin intermediate filamentsJ Muscle Res Cell Motil2002235–653554012785103
   PubMed Web of Science ®Google Scholar
• ByunYChenFChangRTrivediMGreenKJCrynsVLCaspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosisCell Death Differ20018544345011423904
   PubMed Web of Science ®Google Scholar
• KimBHMinYSChoiJSBenzoxathiol derivative BOT-4-one suppresses L540 lymphoma cell survival and proliferation via inhibition of JAK3/STAT3 signalingExp Mol Med201143531332121499010
   PubMed Web of Science ®Google Scholar
• HuYShenYJiBWangLZhangZZhangYCombinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERTEur J Pharm Sci201142438739121238587
   PubMed Web of Science ®Google Scholar